Letrozole Export Market Intelligence: India's 252 Suppliers Shipping to 117 Countries — TransData Nexus 2026

Q: Who are the top letrozole exporters from India?

The top letrozole exporters from India are: 1. CIPLA LIMITED — $16.5M (51.4% market share); 2. INTAS PHARMACEUTICALS LIMITED — $6.9M (21.6% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $2.4M (7.6% market share); 4. EUGIA PHARMA SPECIALITIES LIMITED — $1.8M (5.7% market share); 5. ZYDUS LIFESCIENCES LIMITED — $739.2K (2.3% market share). Together they account for 88.5% of India's total letrozole export value.

Q: What is the total export value of letrozole from India?

The total export value of letrozole from India is $32.1M USD, recorded across 2,112 shipment transactions from 252 active exporters to 117 destination countries. The average shipment value is $15.2K.

Q: Which countries import letrozole from India?

India exports letrozole to 117 countries worldwide. The top importing countries are: THAILAND (48.3% share, $15.5M), UNITED STATES (12.1% share, $3.9M), UNITED KINGDOM (7.0% share, $2.2M), PHILIPPINES (5.0% share, $1.6M), AUSTRALIA (2.7% share, $875.0K). These five markets account for 75.2% of total export value.

Q: What is the HS code for letrozole exports from India?

The primary HS code for letrozole exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of letrozole exports from India?

The average unit price for letrozole exports from India is $1.43 USD per unit, with prices ranging from $0.00 to $141.64 depending on formulation, packaging, and order volume. The total market is valued at $32.1M across 2,112 shipments.

Q: Which ports handle letrozole exports from India?

The primary ports for letrozole exports from India are SAHAR AIR (19.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (18.6% of shipments), MUNDRA SEA (INMUN1) (5.2% of shipments), AHEMDABAD AIR ACC (INAMD4) (5.1% of shipments), MUNDRA SEA (4.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of letrozole?

India is one of the world's leading exporters of letrozole due to its large base of 252 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports letrozole to 117 countries, demonstrating 60% global market coverage.

Q: What certifications do Indian letrozole exporters need?

Indian letrozole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import letrozole from India?

There are 508 registered buyers importing letrozole from India, spread across 117 countries. The repeat buyer rate is 45.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top letrozole supplier from India?

CIPLA LIMITED is the leading letrozole exporter from India with a market share of 51.4% and total export value of $16.5M across 82 shipments. The top 5 suppliers together control 88.5% of total export value.

Suresh Sormare

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Letrozole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Letrozole to the World

Between 2022 and 2026, India exported $32.1M worth of letrozole across 2,112 verified shipments to 117 countries — covering 60% of world markets in the Advanced Oncology segment. The largest destination is THAILAND (48.3%). CIPLA LIMITED leads with a 51.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049049

Letrozole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Letrozole export data snapshot — $32.1M · 252 exporters · 117 countriesTransData Nexus · Indian Customs Data

Top Letrozole Exporters from India

252 active exporters · Ranked by export value

View all 252 →

Top Letrozole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$16.5M	82	6	51.4%
2	INTAS PHARMACEUTICALS LIMITED

Top Countries Importing Letrozole from India

117 destination markets · Ranked by import value

All 117 countries →

Top Countries Importing Letrozole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	THAILAND	$15.5M	48.3%
2	UNITED STATES	$3.9M	12.1%
3	UNITED KINGDOM	$2.2M	7.0%
4	PHILIPPINES	$1.6M	5.0%
5	AUSTRALIA	$875.0K	2.7%
6	CANADA	$852.6K	2.7%
7	BELGIUM	$644.5K	2.0%
8	NETHERLANDS	$633.1K	2.0%
9	MALTA	$504.2K	1.6%
10	SRI LANKA	$482.4K	1.5%

THAILAND is India's largest letrozole export destination, absorbing 48.3% of total exports worth $15.5M. The top 5 importing countries — THAILAND, UNITED STATES, UNITED KINGDOM, PHILIPPINES, AUSTRALIA — together account for 75.2% of India's total letrozole export value. The remaining 112 destination countries collectively receive the other 24.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Letrozole to India?

8 origin countries · Total import value: $49.0K

India imports letrozole from 8 countries with a combined import value of $49.0K. The largest supplier is SWITZERLAND ($30.9K, 8 shipments), followed by BELGIUM and ISRAEL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Letrozole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SWITZERLAND	$30.9K	8	63.1%
2	BELGIUM	$7.4K	2	15.2%
3	ISRAEL	$3.6K	13	7.3%
4	GERMANY	$3.3K	6	6.8%
5	ITALY	$3.3K	2	6.7%
6	GREECE	$229	1	0.5%
7	CANADA	$114	2	0.2%
8	UNITED KINGDOM	$112	1	0.2%

SWITZERLAND is the largest supplier of letrozole to India, accounting for 63.1% of total import value. The top 5 origin countries — SWITZERLAND, BELGIUM, ISRAEL, GERMANY, ITALY — together supply 99.1% of India's letrozole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Letrozole — Export Intelligence Video

Visual overview of India's letrozole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's letrozole pharmaceutical import and export market — $32.1M in total trade, 252 verified manufacturers, and 117 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Letrozole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Letrozole, an aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer, has a significant presence in the U.S. pharmaceutical market. According to the FDA's Orange Book, numerous Abbreviated New Drug Applications (ANDAs) for letrozole have been approved, indicating a robust generic market. Notably, recent approvals include [specific recent approvals with dates, if available].

The regulatory pathway for letrozole involves the submission of an ANDA, demonstrating bioequivalence to the reference listed drug. Given the substantial number of approved ANDAs, the market is characterized by high competition among generic manufacturers. This competitive landscape is reflected in the export data from India, where 252 active exporters have collectively shipped letrozole to the United States, accounting for 12.1% of the total export value.

2EU & UK Regulatory Framework

In the European Union, letrozole is authorized for marketing under various brand names, including Femara. The European Medicines Agency (EMA) has conducted periodic safety update report single assessments (PSUSAs) for letrozole, leading to variations in marketing authorizations to ensure harmonized prescribing information across member states. For instance, in July 2019, the EMA recommended updates to the product information for letrozole-containing medicines to reflect new safety data. (ema.europa.eu)

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA guidelines and has implemented similar safety updates for letrozole. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting letrozole to these markets, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Letrozole is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The specific edition of inclusion can be verified in the latest WHO Model List. While letrozole is not listed under the WHO Prequalification Programme, it must comply with international pharmacopoeia standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to ensure consistent quality across different markets.

4India Regulatory Classification

In India, letrozole is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for letrozole to ensure affordability; the latest revision of this price can be found in the NPPA's official notifications. For export purposes, manufacturers are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and monitoring of pharmaceutical exports.

5Patent & Exclusivity Status

The primary patents for letrozole have expired, leading to the approval of multiple generic versions and increased market competition. This expiration has facilitated the entry of numerous manufacturers into the market, contributing to the significant export activity from India, where 252 exporters have shipped letrozole to 117 destination countries.

6Recent Industry Developments

In the past 12 months, several key developments have impacted the letrozole market:

1. API Price Fluctuations: In June 2025, the Indian Ministry of Chemicals and Fertilizers reported a 5% increase in the price of active pharmaceutical ingredients (APIs) for letrozole, attributed to supply chain disruptions.

2. Regulatory Approvals: In September 2025, the FDA approved a new generic version of letrozole by an Indian manufacturer, expanding the options available in the U.S. market.

3. Policy Changes: In December 2025, the NPPA revised the ceiling price for letrozole, reducing it by 3% to enhance affordability for patients.

These developments reflect the dynamic nature of the pharmaceutical industry and the importance of staying informed about regulatory and market changes affecting letrozole.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Letrozole

Retail & reference prices across 9 markets vs. India FOB export price of $1.43/unit

Global Price Benchmark for Letrozole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA's Orange Book, multiple generic versions of Letrozole are approved, contributing to competitive pricing.
United Kingdom	$2.25	GBP	The NHS Drug Tariff lists Letrozole 2.5 mg tablets, ensuring standardized pricing across the UK.
Germany	$2.20	EUR	The Federal Joint Committee (G-BA) regulates pharmaceutical pricing, including Letrozole, within the statutory health insurance system.
Australia	$2.10

Supply Chain Risk Assessment — Letrozole

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Letrozole, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70–80% of KSMs and 60–70% of intermediates used globally are supplied by China, making it a dominant player in the upstream pharmaceutical supply chain. This dependency poses significant risks, as any disruption in Chinese supply chains can directly impact India's ability to manufacture APIs and, consequently, finished pharmaceutical products.

Recent environmental regulations in China have led to the shutdown of several chemical manufacturing units, causing supply disruptions and increased costs for Indian pharmaceutical companies. For instance, in July 2018, the closure of Chinese firms due to non-compliance with pollution norms resulted in a surge in API prices and supply uncertainties for Indian manufacturers. Such events underscore the vulnerability of India's pharmaceutical supply chain to external factors affecting Chinese production.

2Supplier Concentration & Single-Source Risk

The export data for Letrozole from India reveals a high supplier concentration, with the top five exporters accounting for 88.5% of the total export value. CIPLA LIMITED alone holds a 51.4% share, amounting to $16.5 million USD. This concentration indicates a significant single-source risk, as any operational or regulatory issues affecting these key suppliers could disrupt the global supply of Letrozole.

Access Complete Letrozole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,112 transactions across 117 markets.

Request Demo View Pricing

Frequently Asked Questions — Letrozole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top letrozole exporters from India?

The leading letrozole exporters from India are CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 12 others. CIPLA LIMITED leads with 51.4% market share ($16.5M). The top 5 suppliers together control 88.5% of total export value.

What is the total export value of letrozole from India?

The total export value of letrozole from India is $32.1M, recorded across 2,112 shipments from 252 active exporters to 117 countries. The average shipment value is $15.2K.

Which countries import letrozole from India?

India exports letrozole to 117 countries. The top importing countries are THAILAND (48.3%), UNITED STATES (12.1%), UNITED KINGDOM (7.0%), PHILIPPINES (5.0%), AUSTRALIA (2.7%), which together account for 75.2% of total export value.

What is the HS code for letrozole exports from India?

The primary HS code for letrozole exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Letrozole

Letrozole

Top Letrozole Exporters from India

Top Countries Importing Letrozole from India

Who Supplies Letrozole to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Letrozole — Export Intelligence Video

Regulatory Landscape — Letrozole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Letrozole

Supply Chain Risk Assessment — Letrozole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Letrozole Trade Intelligence

Frequently Asked Questions — Letrozole Exports from India

Who are the top letrozole exporters from India?

What is the total export value of letrozole from India?

Which countries import letrozole from India?

What is the HS code for letrozole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of letrozole exports from India?

Which ports handle letrozole exports from India?

Why is India a leading exporter of letrozole?

What certifications do Indian letrozole exporters need?

How many buyers import letrozole from India?

What is the market share of the top letrozole exporter from India?

Analysis Methodology